NCT01926821View on ClinicalTrials.gov

Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer During Radiation or Chemoradiation Therapy

PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cervical Cancer
Interventions
DRUG

Sonifilan

Sonifilan inj 20mg Intra muscular injection, twice per week for 8 weeks, total 16 times

Trial Locations (1)

Unknown

RECRUITING

JongHyeokKim, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT01926821 - Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer During Radiation or Chemoradiation Therapy | Biotech Hunter | Biotech Hunter